At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SAVAW Cassava Sciences Warrants
Not Yet Opened 11-21 16:00:00 EST
0.0300
+0.0000
0.00%
High0.0300
Low0.0300
Vol0.00
Open0.0300
D1 Closing0.0300
Amplitude0.00%
Mkt Cap0.00
Tradable Cap0.00
Total Shares0.00
T/O0.00
T/O Rate--
Tradable Shares0.00
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year?
Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 6.7% of holdings value
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.